Received Jan 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 1 | LT9HP | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | UT8869BA | IM / LA |
Medical Assistant gave patient both FluLaval and Fluzone at same encounter. Mistake was discovered before patient left the clinic. No symptoms at time of injection.
HTN (hypertension) I25.10 CAD (coronary artery disease) E78.5 Hyperlipidemia E11.9 Type 2 diabetes mellitus without complication, without long-term current use of insulin K21.9 GERD (gastroesophageal reflux disease) J44.9 COPD, severe I50.22 Chronic systolic (congestive) heart failure J96.11 Chronic respiratory failure with hypoxia
Trelegy Ellipta(Fluticasone-Umeclidin-Vilant) 100-62.5-25 MCG/ACT Aerosol Powder Breath ActivatedStart C R S Albuterol Sulfate HFA 108 (90 Base) MCG/ACT Aerosol SolutionTaking C R S Atorvastatin Calcium 40 MG TabletTaking C R S Clopid
Sulfa Antibiotics NSAIDs
n/a